References
Updated December 8, 2022
- Progress toward poliomyelitis eradication – Afghanistan, January 2021 – September 2022
December 2022 - Progress Toward Poliomyelitis Eradication — Pakistan. January 2021–July 2022
October 2022 - Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036
October 2022 - Modeling undetected live type 1 wild poliovirus circulation after apparent interruption of transmission: Pakistan and Afghanistan
June 2022 - Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan
June 2022 - Progress Toward Polio Eradication — Worldwide, January 2020–April 2022
May 2022
- Progress Toward Poliomyelitis Eradication — Pakistan, January 2020–July 2021
October 2021 - Progress Toward Polio Eradication — Worldwide, January 2019–June 2021
August 2021 - Modeling Poliovirus Surveillance and Immunization Campaign Quality Monitoring Costs for Pakistan and Afghanistan for 2019–2023
July 2021 - Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2019–2020
May 2021 - Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response
May 2021 - The impact of disruptions caused by the COVID-19 pandemic on global polio eradication
April 2021 - Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain
February 2021 - Impact of COVID-19 Pandemic on Global Poliovirus Surveillance
January 2021
- Progress Toward Poliomyelitis Eradication — Pakistan, January 2019−September 2020
November 2020 - Randomized Controlled Clinical Trial of bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children.
November 2020 - Immunogenicity of reduced-dose monovalent type 2 oral poliovirus vaccine in Mocuba, Mozambique.
November 2020 - Progress Toward Poliomyelitis Eradication — Afghanistan, January 2019–July 2020
October 2020 - Strengthening National Immunization Technical Advisory Groups in resource-limited settings: current and potential linkages with polio national certification committees
October 2020 - Progress Toward Poliovirus Containment Implementation — Worldwide, 2019–2020
September 2020 - Notes from the Field: CDC Polio Surge Response to Expanding Outbreaks of Type 2 Circulating Vaccine-Derived Poliovirus — Africa and Philippines, September 2019–March 2020
August 2020 - One-year decline of poliovirus antibodies following fractional-dose inactivated poliovirus vaccine.
August 2020 - Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses — Worldwide, July 2018–December 2019
July 2020 - The Long and Winding Road to Eradicate Vaccine-Related Polioviruses.
July 2020 - Estimating population immunity to poliovirus in Lebanon: Results from a seroprevalence survey, 2016.
June 2020 - Progress Toward Polio Eradication — Worldwide, January 2018–March 2020
June 2020 - Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, July 2019–February 2020
April 2020 - Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2018–2019
May 2020 - New analytic approaches for analyzing and presenting polio surveillance data to supplement standard performance indicators.
April 2020 - Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria.
April 2020 - Evolving epidemiology of poliovirus serotype 2 following withdrawal of the type 2 oral poliovirus vaccine.
March 2020 - Immunogenicity of Intramuscular Fractional Dose of Inactivated Poliovirus Vaccine.
March 2020 - Assessment of immunity to polio among Rohingya children in Cox’s Baar, Bangladesh, 2018: A cross-sectional survey.
March 2020 - Global Transmission of Live Polioviruses: Updated Dynamic Modeling of the Polio endgame.
January 2020
- Estimating population immunity to poliovirus in Jordan’s high-risk areas.
November 2019 - Inactivated Poliovirus Vaccine Supply Shortage: Is There Light at the End of the Tunnel?
April 2019 - Update on Vaccine-Derived Poliovirus Outbreaks – Democratic Republic of the Congo and Horn of Africa, 2017-2018.
March 2019 - Poliovirus immunity among children under five years-old in accessible areas of Afghanistan, 2013.
February 2019 - Poliovirus type 2 seroprevalence following full or fractional-dose of inactivated poliovirus vaccine in the period after Sabin type 2 withdrawal in Sri Lanka.
January 2019
Last Reviewed: September 28, 2021
Source: Global Immunization
